Loading clinical trials...
Loading clinical trials...
The purpose of the study is to determine if topically applied nitric oxide gas is effective in reducing the quantity of bacteria (including MRSA)in a wound.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Nitric BioTherapeutics, Inc
NCT06281483 · Chronic Non-healing Skin Ulcers
NCT01817075 · Bacterial Infection, Benign Neoplasm, and more
NCT01028105 · Methicillin-resistant Staphylococcus Aureus Infection
NCT01748318 · Community-acquired Methicillin-resistant Staphylococcus Aureus Infection
NCT02685722 · Difficult to Healing of Skin Ulcers
Department of Wound Healing, Cardiff University
Cardiff
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions